Literature DB >> 15827857

Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism.

Susumu Matsuoka1, Susumu Matstusoka, Yoshihiro Tominaga, Nobuaki Uno, Norihiko Goto, Tetsuhiko Sato, Akio Katayama, Toshihito Haba, Kazuharu Uchida, Keiko Kobayashi, Akimasa Nakao.   

Abstract

Calciphylaxis is a relatively rare but life-threatening complication in uremic patients. Clinical findings and prognosis were evaluated in six patients who developed calciphylaxis from a group of 1499 patients who underwent parathyroidectomy (PTx) for advanced renal hyperparathyroidism (HPT) in our department from July 1972 to July 2003. The frequency of calciphylaxis was 0.40% (6/1499). Two patients were women and four were men. The mean age was 50.5 years, and the mean duration of hemodialysis (HD) treatment was 14.0 years. In five of six patients, calciphylaxis was classified as distal type; in one case, as proximal type. In three patients, calciphylaxis was diagnosed at the time for PTx. In two patients, calciphylaxis was identified after PTx, although the serum parathyroid hormone (PTH) level was within the appropriate range for dialysis patients. In two patients, calciphylaxis improved after PTx, but two patients required leg and toe amputations after PTx. In one patient with the proximal type of calciphylaxis, the condition occurred when a high PTH level recurred after the initial PTx. The patient died as a result of a serious infection due to uncontrollable skin ulcers. Calciphylaxis is a rare complication in patients who require PTx for renal HPT. Especially the proximal type has a poor prognosis. High levels of the Ca x P product and/or PTH are risk factors. Therefore, this syndrome should be kept in mind and attention should be paid to reduce risk factors. It is important that PTx being performed at the right time in patients with advanced renal HPT refractory to medical treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15827857     DOI: 10.1007/s00268-005-7514-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Calcific uremic arteriolopathy (calciphylaxis): an evolving entity?

Authors:  F Llach
Journal:  Am J Kidney Dis       Date:  1998-09       Impact factor: 8.860

2.  Calciphylaxis in two non-compliant patients with end-stage renal failure.

Authors:  K McAuley; F Devereux; R Walker
Journal:  Nephrol Dial Transplant       Date:  1997-05       Impact factor: 5.992

3.  Systemic calciphylaxis revisited.

Authors:  H J Adrogué; M R Frazier; B Zeluff; W N Suki
Journal:  Am J Nephrol       Date:  1981       Impact factor: 3.754

4.  Dramatic worsening of vascular calcifications after kidney transplantation in spite of early parathyroidectomy.

Authors:  C Canavese; F Cesarani; C Stratta; E Maddalena; M Messina; D Hamido; D S Bianchi; G P Segoloni
Journal:  Clin Nephrol       Date:  2000-12       Impact factor: 0.975

5.  Calciphylaxis in patients on hemodialysis: a prevalence study.

Authors:  M Angelis; L L Wong; S A Myers; L M Wong
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

6.  Proximal cutaneous necrosis associated with small vessel calcification in renal failure.

Authors:  C N Ross; M J Cassidy; M Thompson; R Russell Jones; A J Rees
Journal:  Q J Med       Date:  1991-05

7.  Cryofibrinogenemia: an addition to the differential diagnosis of calciphylaxis in end-stage renal disease.

Authors:  S Sankarasubbaiyan; G Scott; J L Holley
Journal:  Am J Kidney Dis       Date:  1998-09       Impact factor: 8.860

Review 8.  Cutaneous necrosis from calcific uremic arteriolopathy.

Authors:  T Coates; G S Kirkland; R B Dymock; B F Murphy; J K Brealey; T H Mathew; A P Disney
Journal:  Am J Kidney Dis       Date:  1998-09       Impact factor: 8.860

9.  The vascular lesions associated with skin necrosis in renal disease.

Authors:  Y L Chan; J F Mahony; J J Turner; S Posen
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

Review 10.  Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy.

Authors:  J Hafner; G Keusch; C Wahl; B Sauter; A Hürlimann; F von Weizsäcker; M Krayenbühl; K Biedermann; U Brunner; U Helfenstein
Journal:  J Am Acad Dermatol       Date:  1995-12       Impact factor: 11.527

View more
  4 in total

1.  Secondary hyperparathyroidism: Uncommon cause of a leg ulcer.

Authors:  L B van Rijssen; E E A Brenninkmeijer; E J M Nieveen van Dijkum
Journal:  Int J Surg Case Rep       Date:  2011-10-28

2.  Recurrent renal hyperparathyroidism caused by parathyromatosis.

Authors:  Susumu Matsuoka; Yoshihiro Tominaga; Tetsuhiko Sato; Nobuaki Uno; Norihiko Goto; Akio Katayama; Kazuharu Uchida; Toyonori Tsuzuki
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

3.  Calciphylaxis associated with chronic kidney disease and low bone turnover: management with recombinant human PTH-(1-34).

Authors:  Grahame Elder; Karthic S Kumar
Journal:  NDT Plus       Date:  2008-02-14

4.  Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kitravee Kongnatthasate; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.